A Phase 1b/2a, Open-Label, Multi-Center Study of AV-951 in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer.

Trial Profile

A Phase 1b/2a, Open-Label, Multi-Center Study of AV-951 in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Jul 2013

At a glance

  • Drugs Tivozanib (Primary) ; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 30 Jun 2012 The Phase 2a study portion of the study was not conducted.
    • 08 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 May 2011 Phase I results will be presented at the Annual Meeting of the American Society of Oncology (ASCO-2011).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top